Orchid Pharma Ltd - 524372 - Outcome of Board Meeting
OUTCOME OF MEETING- APPROVAL OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER/NINE MONTHS ENDED DECEMBER 31,201813-02-2019
Orchid Pharma Ltd - 524372 - Outcome of Board Meeting
OUTCOME OF MEETING- APPROVAL OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER/NINE MONTHS ENDED DECEMBER 31,2018Orchid Pharma Ltd - 524372 - Board Meeting Intimation for TO CONSIDER AND APPROVE THE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED DECEMBER 31,2018
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED DECEMBER 31,2018Orchid Pharma Ltd - 524372 - Approval Of Unaudited Financial Results For The Quarter/Half Year Ended September 30,2018
Approval of Unaudited financial results for the quarter/half year ended September 30,2018Orchid Pharma Ltd - 524372 - Outcome of Board Meeting
Approval of Unaudited standalone financial results for the quarter/half-year ended September 30,2018Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Qarter Ended 30Th September 2018 - Q2 Of FY 2018-19)
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2019 ,inter alia, to consider and approve Consider and approve the unaudited financial results for the qarter ended 30th September 2018 - Q2 of FY 2018-19)Orchid Pharma Ltd - 524372 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0431 Name of the Signatory :- L CHANDRASEKARDesignation :- Company Secretary and Compliance OfficerOrchid Pharma Ltd - 524372 - Shareholding for the Period Ended December 31, 2018
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click hereDisclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Orchid Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereShareholder Meeting / Postal Ballot-Scrutinizer''s Report
OUTCOME OF THE 25TH ANNUAL GENERAL MEETING-SCRUTINISER''S REPORTShareholder Meeting / Postal Ballot-Outcome of AGM
PROCEEDINGS OF THE 25TH ANNUAL GENERAL MEETING